Toronto Dominion Bank Gilead Sciences, Inc. Transaction History

Toronto Dominion Bank

$55.7 Billion
Q3 2024

A detailed history of Toronto Dominion Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 639,972 shares of GILD stock, worth $56.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

639,972

Previous 666,424 3.97%

Holding current value

$56.6 Million

Previous $45.7 Million 17.32%

% of portfolio

0.1%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $1.76 Million - $2.22 Million	-26,452 Reduced 3.97%	639,972 $53.6 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $15.5 Million - $17.9 Million	246,183 Added 58.58%	666,424 $45.7 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $1.49 Million - $1.82 Million	-20,857 Reduced 4.73%	420,241 $30.8 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $62.1 Million - $70.4 Million	-847,786 Reduced 65.78%	441,098 $35.7 Million
Q3 2023 Feb 14, 2024	BUY	$73.94 - $80.67 $38.1 Million - $41.6 Million	515,191 Added 66.59%	1,288,884 $96.6 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $38.1 Million - $41.6 Million	515,191 Added 66.59%	1,288,884 $96.6 Million
Q2 2023 Feb 14, 2024	BUY	$76.01 - $86.7 $25.3 Million - $28.8 Million	332,595 Added 75.4%	773,693 $59.6 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $54.2 Million - $61.8 Million	-712,545 Reduced 47.94%	773,693 $59.6 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $62.6 Million - $71.3 Million	810,051 Added 119.8%	1,486,238 $123 Million
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $5.77 Million - $8.28 Million	92,572 Added 15.86%	676,187 $58 Million
Q3 2022 Nov 09, 2022	SELL	$59.54 - $68.01 $16.2 Million - $18.6 Million	-272,904 Reduced 31.86%	583,615 $36 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $11.6 Million - $13 Million	-200,361 Reduced 18.96%	856,519 $52.9 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $16.1 Million - $20.1 Million	277,116 Added 35.54%	1,056,880 $62.8 Million
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $3.65 Million - $4.14 Million	56,211 Added 7.77%	779,764 $56.6 Million
Q3 2021 Nov 08, 2021	BUY	$67.69 - $73.03 $7.77 Million - $8.39 Million	114,820 Added 18.86%	723,553 $50.5 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $38.6 Million - $42.2 Million	608,733 New	608,733 $41.9 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Account

Toronto Dominion Bank Gilead Sciences, Inc. Transaction History